Pharmaceutical Manufacturers Association of Türkiye

What Pharmaceutical Manufacturers Association of Türkiye does

İEİS (İlaç Endüstrisi İşverenler Sendikası), the Pharmaceutical Manufacturers Association of Türkiye, is an employers' syndicate founded in 1964 that represents pharmaceutical manufacturers operating in Turkey. Headquartered in Istanbul with a secondary office in Ankara focused on government relations, the association serves approximately 50 member companies spanning domestic leaders such as Abdi İbrahim, Bilim İlaç, and Adeka, alongside multinational subsidiaries including Abbott Laboratories and Sandoz. Its scope of representation covers the broader Turkish pharmaceutical industry, which collectively employs approximately 30,000 people across nearly 300 organizations, produces 89% of consumed drugs domestically by unit, and exports approximately $2 billion worth of pharmaceuticals to nearly 190 countries.

İEİS does not sell products or services in the commercial sense; rather, it generates revenue through member dues and operates as a coordinating industry body. Its core activities are organized across eleven working groups covering pricing and reimbursement, licensing, R&D and academic relations, production and localization, HR, legal/tax/IP, nutrition, and corporate communications. The association also operates two specialized platforms: the Turkish Pharmaceutical Exporters Platform (established 2012) and the Turkish Biopharmaceuticals Platform (established 2016), each designed to coordinate industry-wide initiatives in their respective domains. Its published outputs include the annual Turkish Pharmaceutical Industry Report, sectoral analyses, and UN Global Compact progress reports, complemented by events, trade missions, and press activities.

The association's go-to-market is fundamentally sales- and advocacy-led: it engages Turkish regulatory bodies (TİTCK, Ministry of Health, SGK) on pricing, reimbursement, and licensing policy; coordinates with international bodies including Medicines for Europe and the Gulf Cooperation Council on cross-border initiatives; and represents member interests in public discourse. With partnerships spanning government agencies, academic institutions, and industry associations, İEİS functions as the unified voice of the Turkish pharmaceutical industry in policy and market access matters. The organization's current leadership is headed by Board Chairman Nezih Barut and General Secretary Savaş Malkoç.

Name

Pharmaceutical Manufacturers Association of Türkiye

Legal name

İlaç Endüstrisi İşverenler Sendikası

Website

https://ieis.org.tr

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

11–50 employees

Short description

İEİS is the Pharmaceutical Manufacturers Association of Türkiye, an employers' syndicate founded in 1964 that represents approximately 50 domestic and multinational pharmaceutical manufacturers through policy advocacy, regulatory engagement, and export promotion.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association Services

NAICS

Professional Organizations (813920), Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

akta.pro secondary industry

Economic Research, Statistics & Policy Advisory (BPADAMAJ)

Keywords

• Pharmaceutical industry association
• Regulatory advocacy services
• Industry working groups
• Trade association membership
• Pharmaceutical export promotion

Headquarters

HQ city

Kagithane

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: IEIS generates revenue through membership fees from pharmaceutical manufacturer companies operating in Turkey.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

İEİS is an employers' syndicate representing pharmaceutical manufacturers in Turkey. Its core offering centers on policy advocacy, regulatory representation, and industry coordination for member companies, delivered through working groups covering pricing, reimbursement, licensing, R&D, production, HR, and legal/IP matters; specialized platforms for biopharmaceuticals and pharmaceutical exports; publications including the annual Turkish Pharmaceutical Industry Report; and engagement with national authorities (Ministry of Health, TITCK, SGK) and international bodies (Medicines for Europe, UN Global Compact).

Product overview

The Pharmaceutical Manufacturers Association of Türkiye (İEİS) is a pharmaceutical industry employers' union that serves as a coordinating body for member companies. Rather than offering a unified product platform, IEIS provides a portfolio of industry-specific services including the annual Turkish Pharmaceutical Industry Report, two specialized platforms (Turkish Biopharmaceuticals Platform and Turkish Pharmaceutical Exporters Platform), and various working groups covering areas such as pricing, licensing, R&D, production, and legal/regulatory matters. The association also publishes sectoral analyses, foreign trade reports, and industry bulletins to support the Turkish pharmaceutical sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Türkiye İlaç Sektörü Raporu (Turkish Pharmaceutical Industry Report) Annual comprehensive report analyzing the Turkish pharmaceutical and medical products market, covering licensing, investment incentives, R&D, production, employment, foreign trade, and financial data; produced for member companies and industry stakeholders.
• Türkiye Biyoteknolojik İlaç ve Aşı Platformu (Turkish Biopharmaceuticals Platform) Industry platform established by İEİS in 2016 to advance biopharmaceuticals and vaccines in Turkey, with participation from biotechnology companies beyond İEİS members, supporting regulatory frameworks, incentive schemes, and professional awareness.
• Türkiye İlaç İhracatçıları Platformu (Turkish Pharmaceutical Exporters Platform) Platform established by İEİS in 2012 to promote the Turkish pharmaceutical industry's standards in international markets and increase its competitiveness for global export leadership, supporting exporter companies with policy and strategy coordination.
• İEİS Tanıtım Broşürü (İEİS Promotional Brochure) Introductory brochure about the Pharmaceutical Manufacturers Association of Turkey, used to communicate the association's mission and activities to prospective members and stakeholders.

Quantifiable outcome

• 89% domestic production by unit, 53% by value
• +1 more outcomes

Named customers10 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered minor and core.

• Ankara University Faculty of PharmacyminorStrategic or Co-development Partner · 1 January 2026IEIS collaborated with Ankara University Faculty of Pharmacy to host 'Future Meeting in Pharmaceutical Industry for Pharmacists' event on April 16, 2026.
• Turkish Pharmacists AssociationminorStrategic or Co-development Partner · 1 January 2026Turkish Pharmacists Association participated in the 'Future Meeting in Pharmaceutical Industry for Pharmacists' event co-hosted with IEIS and Ankara University.
• Turkish Biopharmaceuticals PlatformcoreStrategic or Co-development Partner · 1 January 2016Established in 2016 to contribute to the development of biopharmaceuticals field in Turkey. Platform works with companies in biotechnology field to develop regulatory frameworks, incentive schemes, and professional awareness.
• Gulf Cooperation Countries Council (GCC)coreStrategic or Co-development Partner · 1 January 2013IEIS organized Turkey-GCC Pharmaceuticals and Medical Devices Meeting in Istanbul with cooperation of Turkish Pharmaceuticals and Medical Devices Agency. Aims to establish cooperation with GCC countries in pharmaceuticals and medical devices.
• Turkish Pharmaceutical Exporters PlatformcoreStrategic or Co-development Partner · 1 January 2012Established in 2012 to promote Turkish pharmaceutical industry in international markets and increase export volume. Platform coordinates with IEIS member companies to develop export policies and strategies.
• European Generic Medicines Association (EGA)coreStrategic or Co-development Partner · 1 January 2007IEIS is a member of the European Generic Medicines Association. Hosted the 13th EGA Annual Meeting in Istanbul in 2007 with 450 participants from many countries.
• Medicines for EuropecoreStrategic or Co-development PartnerIEIS collaborates with Medicines for Europe on regulatory affairs and pharmacovigilance conferences and events.
• Turkish Pharmaceuticals and Medical Devices Agency (TİTCK)coreStrategic or Co-development PartnerIEIS cooperates with TİTCK on regulatory matters, pharmaceutical policy, and market access for the Turkish pharmaceutical industry.
• Social Security Institution (SGK)coreStrategic or Co-development PartnerIEIS engages with SGK on pricing, reimbursement policies, and pharmaceutical reimbursement processes for member companies.
• United Nations Global CompactminorStrategic or Co-development PartnerIEIS joined the UN Global Compact in 2010, committing to sustainable and responsible business practices in the pharmaceutical industry.

Scale indicators6 records

Recent moves14 records

Expansion highlights5 records

Direct peers

• Farmaindustria: Spanish pharmaceutical industry trade association representing manufacturers operating in Spain. Directly comparable as a national pharma industry body performing pricing/reimbursement advocacy and international promotion, similar to IEIS's mandate in Turkey.
• Pharma.be: Belgian pharma industry association representing innovative pharmaceutical companies. Comparable to IEIS as a national trade body performing policy advocacy, member coordination, and international engagement, albeit with a smaller member base.
• JPMA — Japan Pharmaceutical Manufacturers Association: Japanese pharma manufacturers association representing R&D-based pharmaceutical companies. Comparable to IEIS as a national industry body with strong international engagement and a focus on regulatory cooperation and export promotion.
• Medicines Australia: Australian pharma industry association representing prescription medicine manufacturers. Comparable to IEIS as a national association focused on industry advocacy, member services, and policy engagement with health authorities.
• ABPI — Association of the British Pharmaceutical Industry: U.K. national pharma trade association representing manufacturers on policy, pricing, and international access. Closely mirrors IEIS's structure as a single-country industry association performing advocacy and member services.
• EFPIA — European Federation of Pharmaceutical Industries and Associations: European-level pharma industry federation representing national associations and manufacturers. Directly comparable to IEIS in its role as a coordinating industry voice, and is a natural supranational counterpart that IEIS engages with through partners like Medicines for Europe.
• Indian Pharmaceutical Alliance: Indian pharma industry alliance representing leading Indian generic manufacturers. Directly comparable to IEIS in representing an emerging-market pharma manufacturing base with significant export orientation and a focus on regulatory and policy advocacy.
• PhRMA — Pharmaceutical Research and Manufacturers of America: U.S. national pharmaceutical industry association representing research-based pharma manufacturers. Directly comparable to IEIS as the principal trade body for U.S. drug manufacturers, performing advocacy, policy, and international promotion roles analogous to IEIS's mandate in Turkey.
• BPI — Bundesverband der Pharmazeutischen Industrie: German pharmaceutical industry association representing manufacturers and service providers. Directly comparable as a major national pharma trade body with similar advocacy, regulatory engagement, and member-service functions to IEIS.

Broad incumbents

• Medicines for Europe: European generics and biosimilars industry association. Comparable to IEIS in mandate and an explicit partner of IEIS; however, it operates at a supranational level and represents the broader European off-patent medicines industry rather than a single national jurisdiction.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/ieiseu
• Facebookfacebook.com/ilacendustrisiisverenlersendikasi
• LinkedInlinkedin.com/company/pharmaceutical-manufacturers-association-of-turkey-ila-end-strisi-i-verenler-sendikas-ieis-
• Instagraminstagram.com/ieis

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaceutical Manufacturers Association of Türkiye